| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |